An update in August after the split leaves investors with fewer questions for Tuesday's results.
When the pharmaceutical company Johnson & Johnson reports its quarterly financial results on Tuesday morning, it will mark the company’s first financial report that doesn’t include the results of its consumer health division that separated from the company over the summer.
Wall Street analysts expect Johnson & Johnson to report earnings of $2.52 per share for the third quarter and sales of $21 billion, according to FactSet. Sales were $42.4 billion for the first two quarters of the year, excluding the parts of the business that are now within Kenvue. Of that sum, $27.1 billion was in the company’s pharmaceutical division and $15.3 billion was in its medical device division.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Bank of America reports, Johnson & Johnson, retail sales: 3 things to watchBank of America reports, Johnson & Johnson, retail sales: 3 things to watch
Les mer »
Here's what all the major analysts expect from Goldman Sachs' earnings TuesdayThe bank is scheduled to report its third-quarter earnings on Tuesday before the market opens.
Les mer »
Earnings playbook: Netflix and Goldman Sachs headline a big week of reportsExpectations for the overall earnings season are muted.
Les mer »
Tesla reports earnings this week, and it's 'all about margins'Many investors wonder ‘if Tesla can grow earnings at all’
Les mer »
U.S. stocks jump ahead of a wave of corporate earnings reports, economic dataU.S. stocks jump ahead of a wave of corporate earnings reports, economic data
Les mer »
Stocks Are Poised to Rise MondayThis week includes earnings reports from Tesla, Netflix, and Goldman Sachs.
Les mer »